Quantitative objective markers for upper and lower motor neuron dysfunction in ALS

Neurology

Volumn 68, Issue 17, 2007, Pages 1402-1410

  Mitsumoto, H ^a,e   Ulug A M ^d   Pullman, S L ^a   Gooch, C L ^a   Chan, S ^b   Tang, M X ^b,c   Mao, X ^d   Hays, A P ^b   Floyd, A G ^a   Battista, V ^a   Montes, J ^a   Hayes, S ^a   Dashnaw, S ^b   Kaufmann, P ^a   Gordon, P H ^a   Hirsch, J ^b   Levin, B ^b   Rowland, L P ^a   Shungu, D C ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Cornell University ^*  (United States)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; N ACETYLASPARTIC ACID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; MOTOR NERVE CONDUCTION; MOTOR UNIT; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; TIBIALIS ANTERIOR MUSCLE; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ASPARTIC ACID; BIOLOGICAL MARKERS; CREATINE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOTOR CORTEX; MOTOR NEURON DISEASE; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NEURAL CONDUCTION; PROSPECTIVE STUDIES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34247469709     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000260065.57832.87     Document Type: Article

References (54)

1. Kaufmann P, Mitsumoto H. Amyotrophic lateral sclerosis: objective upper motor neuron markers. Curr Neurol Neurosci Rep 2002;2:55-60.
2. Chan S, Kaufmann P, Shungu DC, Mitsumoto H. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimag Clin North Am 2003;13:307-326.
3. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933-1938.
4. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997;48:878-881.
5. Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50:72-77.
6. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51:1104-1109.
7. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N- acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757-1761.
8. 1H-Magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999;169:84-86.
9. Chan S, Shungu DC, Douglas-Akinwande A, Lange D, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999;212:763-769.
10. 1H-MRS evidence of neurodegeneration and excess glutamate and glutamine in ALS medulla. Neurology 1999;53: 71-79.
11. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000;21:647-658.
12. Abe K, Takanishi M, Watanabe Y, et al. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 2001;43:537-541.
13. Pohl C, Block W, Karitzky J, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001;58: 729-735.
14. Sarchielli P, Pelliccioli GP, Tarducci R, et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001;43:189-197.
15. Suhy J, Miller RG, Rule R, et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 2002;58:773-779.
16. Kaufmann P, Pullman SL, Shungu DC, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62:1753-1757.
17. Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler 2004;5:141-149.
18. Bowen BC, Bradley WG. Amyotrophic lateral sclerosis: the search for a spectroscopic marker of upper motor neuron involvement. Arch Neurol 2001;58:714-716.
19. Ellis CM, Simmons A, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999;53:1051-1058.
20. Graham JM, Papadakis N, Evans J, et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004;63:2111-2119.
21. Sach M, Winkler G, Glauche V, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127(Pt 2):340-350.
22. Uluǧ AM, Grunewald T, Lin MT, et al. Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J Magn Res Imag 2004;19:34-39.
23. Miscio G, Pisano F, Mora G, Mazzini L. Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis. Clin Neurophysiol 1999;110: 975-981.
24. Schulte-Mattler WJ, Müller T, Zierz S. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci 1999;170:51-56.
25. Triggs WJ, Menkes D, Onorato J, et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999;53:605-611.
26. Claus D, Brunholzl C, Kerling FP, Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci 1995; 129(suppl):30-34.
27. Eisen A, Shytbel W, Murphy K, Hoirch M. Cortical magnetic stimulation in amyotrophic lateral sclerosis. Muscle Nerve 1990;13:146-151.
28. Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 2003;126:2558-2566.
29. Gooch C, Kaufmann P. Multiple point stimulation motor unit number estimation with single motor unit tracking in a therapeutic ALS trial. Clin Neurophysiol 2003; 55(suppl):284-285.
30. Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D. Northeast ALS Consortium. The use of statistical MUNE in a multicenter clinical trial. Muscle Nerve 2004;30:463-469.
31. Gooch CL, Shefner JM. ALS surrogate markers. MUNE. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5(Suppl 1):104-107.
32. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107 (www.wfnals.org).
33. Kent-Braun JA, Walker CH, Weiner MW, Miller RG. Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve 1998;21:762-768.
34. Sorensen EJ. Assessment of strength measurements. Amyotroph Lateral Scler 2004;5(suppl 1):86-89.
35. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:937-941.
36. BDNF Study Group. A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology 1999;52:1427-1433.
37. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
38. Gordon PH, Miller RG, Moore DH. ALSFRS-R. Amyotroph Lateral Scler 2004;5(suppl 1):90-93.
39. Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64:38-43.
40. Duyn JH, Gillen J, Sobering G, van Zijl PCM, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282.
41. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton spectroscopic imaging of the human brain. Magn Res Med 1996;35:356-363.
42. Uluǧ AM, van Zijl PCM. Orientation-independent diffusion imaging without tensor diagonalization: anisotropy definitions based on physical attributes of the diffusion ellipsoid. J Magn Res Imag 1999;9:804-813.
43. Mitsumoto H, Floyd A, Tang M-X, et al. Transcranial magnetic stimulation for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Clin Neurophysiol (Suppl) 2006;59:321-326.
44. Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647-653.
45. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
46. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-1060.
47. Wang S, Melhem ER. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers. Ann NY Acad Sci 2005; 1064:61-77.
48. Pohl C, Block W, Traber F, et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001;190:21-27.
49. de Carvalho M, Chio A, Dengler R, Hecht M, Weber M, Swash M. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler 2005;6:17-28.
50. Eisen A, Weber M. Neurophysiological evaluation of cortical function in the early diagnosis of ALS. Amyotroph Lat Scler 2000;1(suppl 1):S47-51.
51. Weber M, Eisen A. Peristimulus time histograms (PSTHs) - a marker for upper motor neuron involvement in ALS? Amyotroph Lateral Scler 2000;1(suppl 2):S51-S56.
52. Miller TM, Johnston SC. Should the Babinski sign be part of the routine neurological examination? Neurology 2005; 65:1165-1168.
53. Mildvan D, Landay A, De Gruttola V, Machado SG, Kagan J. An approach to the validation of markers for use in AIDS clinical trials. Clin Infect Dis 1997;24:764-774.
54. Miller RG, Anderson FA Jr, Bradley WG, et al. The ALS Patient Care Database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology 2000;54:53-57.